Key Takeaways
- • Princeton University reduced its long-term return expectation from 10.2% to 8% in February 2026, citing weak private equity performance as the primary driver of the downward revision.
- • Yale University, traditionally a private equity benchmark, has begun reducing exposure by selling approximately $3 billion (15% of its private equity holdings) by 2025, despite maintaining the largest allocation among peer institutions at 35-40%.
- • Comparative performance analysis reveals private equity's underperformance relative to alternatives: Yale's 10-year annualized return of 9.4% trails Norway's Norges sovereign wealth fund at 8.5% (with zero PE exposure) and underperforms on risk-adjusted basis.
- • Leading endowments are shifting strategy toward secondary market sales to address liquidity pressures and duration risk, signaling a structural reassessment of private equity's role in long-term institutional portfolios.
- • The debate reflects a broader institutional consensus that private equity's historical premium—once considered essential for above-average returns—may no longer justify its illiquidity, complexity, and fee structure.
Summary
American university endowments, long considered the gold standard for private equity allocation strategy, are fundamentally reconsidering their exposure to the asset class. This shift marks a significant inflection point: for decades, private equity was viewed as essential for generating above-average long-term returns. Now, the benchmarks that shaped this conventional wisdom are reducing allocations and revising return expectations downward.
Princeton's February 2026 annual letter crystallized this pivot by announcing a reduction in its long-term return expectation from 10.2% to 8%, with private equity weakness cited as the direct cause. This move carries disproportionate weight within the institutional investor community given Princeton's influence. Equally significant, Yale University—the institution that helped establish private equity as a global investment benchmark—has begun a partial retreat, with plans to divest approximately $3 billion in private equity holdings, representing 15% of its total exposure by 2025. Yale maintains the largest allocation among comparable institutions at 35-40%, yet even this commitment is no longer beyond question.
Comparative performance data underscores why institutional skepticism has intensified. Analysis by family office Longview Capital reveals that Yale's 10-year annualized private equity return of 9.4% underperforms alternative approaches: Norway's Norges sovereign wealth fund achieved 8.5% over the same period despite maintaining zero private equity exposure, while Canada's Maple Model pension fund returned 6.9% annualized over ten years with only 20% allocation. Yale's one-year return of 11.1% and Norges' 15.1% demonstrate recent performance variance, but the decade-long comparison exposes private equity's failure to justify its illiquidity and concentration risk premium.
The shift reflects mounting institutional concern over liquidity constraints and fee structures. Leading endowments are now turning to secondary markets to sell private equity stakes to other investors before maturity, typically at discounts to manager valuations. This activity signals that stewards of intergenerational capital are prioritizing liquidity management and duration risk reduction over the historical pursuit of return pickup. The debate among America's elite institutions—those with the greatest resources and sophistication to evaluate private equity—suggests the asset class's golden age may be concluding, forcing a fundamental reallocation across institutional portfolios globally.
Princeton's February 2026 annual letter crystallized this pivot by announcing a reduction in its long-term return expectation from 10.2% to 8%, with private equity weakness cited as the direct cause. This move carries disproportionate weight within the institutional investor community given Princeton's influence. Equally significant, Yale University—the institution that helped establish private equity as a global investment benchmark—has begun a partial retreat, with plans to divest approximately $3 billion in private equity holdings, representing 15% of its total exposure by 2025. Yale maintains the largest allocation among comparable institutions at 35-40%, yet even this commitment is no longer beyond question.
Comparative performance data underscores why institutional skepticism has intensified. Analysis by family office Longview Capital reveals that Yale's 10-year annualized private equity return of 9.4% underperforms alternative approaches: Norway's Norges sovereign wealth fund achieved 8.5% over the same period despite maintaining zero private equity exposure, while Canada's Maple Model pension fund returned 6.9% annualized over ten years with only 20% allocation. Yale's one-year return of 11.1% and Norges' 15.1% demonstrate recent performance variance, but the decade-long comparison exposes private equity's failure to justify its illiquidity and concentration risk premium.
The shift reflects mounting institutional concern over liquidity constraints and fee structures. Leading endowments are now turning to secondary markets to sell private equity stakes to other investors before maturity, typically at discounts to manager valuations. This activity signals that stewards of intergenerational capital are prioritizing liquidity management and duration risk reduction over the historical pursuit of return pickup. The debate among America's elite institutions—those with the greatest resources and sophistication to evaluate private equity—suggests the asset class's golden age may be concluding, forcing a fundamental reallocation across institutional portfolios globally.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.